Published online before print September 16, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,1,1
,2
* The Hospital for Sick Children Research Institute, Toronto, Canada;
Institute of Medical Science, and
Canadian Institutes of Health Research Group in Matrix Dynamics, University of Toronto, Toronto, Canada; and
Biotechnology Research Institute, National Research Council Canada, Montreal, Canada
2. Correspondence: The Hospital for Sick Children, 555 University Ave., Room 5264, Toronto, Ontario, Canada M5G 1X8. E-mail: lisa.robinson{at}sickkids.ca
ABSTRACT
In inflammatory diseases, circulating neutrophils are recruited to sites of injury. Attractant signals are provided by many different chemotactic molecules, such that blockade of one may not prevent neutrophil recruitment effectively. The Slit family of secreted proteins and their transmembrane receptor, Robo, repel axonal migration during CNS development. Emerging evidence shows that by inhibiting the activation of Rho-family GTPases, Slit2/Robo also inhibit migration of other cell types toward a variety of chemotactic factors in vitro and in vivo. The role of Slit2 in inflammation, however, has been largely unexplored. We isolated primary neutrophils from human peripheral blood and mouse bone marrow and detected Robo-1 expression. Using video-microscopic live cell tracking, we found that Slit2 selectively impaired directional migration but not random movement of neutrophils toward fMLP. Slit2 also inhibited neutrophil migration toward other chemoattractants, namely C5a and IL-8. Slit2 inhibited neutrophil chemotaxis by preventing chemoattractant-induced actin barbed end formation and cell polarization. Slit2 mediated these effects by suppressing inducible activation of Cdc42 and Rac2 but did not impair activation of other major kinase pathways involved in neutrophil migration. We further tested the effects of Slit2 in vivo using mouse models of peritoneal inflammation induced by sodium periodate, C5a, and MIP-2. In all instances, Slit2 reduced neutrophil recruitment effectively (P<0.01). Collectively, these data demonstrate that Slit2 potently inhibits chemotaxis but not random motion of circulating neutrophils and point to Slit2 as a potential new therapeutic for preventing localized inflammation.
Key Words: chemotaxis • inflammation • leukocyte trafficking
